NGDRX
Price
$27.34
Change
-$0.03 (-0.11%)
Updated
May 9 closing price
Net Assets
2.33B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

NGDRX vs RGAHX

Header iconNGDRX vs RGAHX Comparison
Open Charts NGDRX vs RGAHXBanner chart's image
Neuberger Berman Large Cap Growth R3
Price$27.34
Change-$0.03 (-0.11%)
VolumeN/A
Net Assets2.33B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
NGDRX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NGDRX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGDRX is a StrongBuy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. NGDRX (2.33B). RGAHX pays higher dividends than NGDRX: RGAHX (0.54) vs NGDRX (0.00). NGDRX was incepted earlier than RGAHX: NGDRX (16 years) vs RGAHX (9 years). NGDRX (1.29) is less costly to investors than RGAHX (0.44). NGDRX is a more actively managed with annual turnover of: 30.00 vs. RGAHX (25.00). NGDRX has a lower initial minimum investment than RGAHX: NGDRX (0) vs RGAHX (250). NGDRX annual gain was more profitable for investors over the last year : 3.48 vs. RGAHX (3.25). NGDRX return over 5 years is better than : 47.54 vs. RGAHX (44.87).
NGDRXRGAHXNGDRX / RGAHX
Total Expense Ratio1.290.44293%
Annual Report Gross Expense Ratio1.290.44293%
Fund Existence16 years9 years-
Gain YTD-3.563-2.478144%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.33B285B1%
Annual Yield % from dividends0.000.54-
Returns for 1 year3.483.25107%
Returns for 3 years28.6733.4086%
Returns for 5 years47.5444.87106%
Returns for 10 years37.43N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics